Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 200,367 |
|
|||||
| News | - | ||||||
| Day High | 34.16 | Low High |
|||||
| Day Low | 33.725 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Inhibrx Inc | INBX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.03 | -0.09% | 34.06 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 34.16 | 33.725 | 34.16 | 34.06 | 34.09 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,270 | 200,367 | US$ 34.04 | US$ 6,820,449 | - | 14.305 - 39.79 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:01 | formt | 264 | US$ 34.06 | USD |
Inhibrx Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.61B | 47.39M | - | 1.8M | -241.36M | -5.09 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Inhibrx News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INBX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 34.40 | 34.595 | 33.725 | 34.19 | 295,021 | -0.34 | -0.99% |
| 1 Month | 34.96 | 35.42 | 33.725 | 34.69 | 435,518 | -0.90 | -2.57% |
| 3 Months | 37.68 | 39.79 | 33.725 | 35.81 | 479,207 | -3.62 | -9.61% |
| 6 Months | 15.52 | 39.79 | 14.305 | 32.99 | 595,164 | 18.54 | 119.46% |
| 1 Year | 19.93 | 39.79 | 14.305 | 28.29 | 503,809 | 14.13 | 70.90% |
| 3 Years | 19.41 | 47.90 | 7.67 | 25.83 | 416,590 | 14.65 | 75.48% |
| 5 Years | 19.70 | 50.97 | 7.67 | 25.91 | 360,877 | 14.36 | 72.89% |
Inhibrx Description
| Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency. |
